|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.5922 USD | -3.06% |
|
-2.89% | -4.02% |
| May. 05 | Lexaria Bioscience Corp. Updates Progress on Human Study #7 | CI |
| Apr. 29 | Lexaria Bioscience Corp and Pharmaceutical Company Extend Material Transfer Agreement | CI |
| Capitalization | 14.68M 12.63M 11.55M 11.02M 20.2M 1.41B 20.53M 139M 53.62M 669M 55.09M 53.91M 2.33B | P/E ratio 2026 * |
-2.28x | P/E ratio 2027 * | -1.91x |
|---|---|---|---|---|---|
| Enterprise value | 14.68M 12.63M 11.55M 11.02M 20.2M 1.41B 20.53M 139M 53.62M 669M 55.09M 53.91M 2.33B | EV / Sales 2026 * |
-
| EV / Sales 2027 * | 10.5x |
| Free-Float |
92.48% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | -3.06% | ||
| 1 week | -2.89% | ||
| Current month | -10.14% | ||
| 1 month | -39.88% | ||
| 3 months | -4.87% | ||
| 6 months | -44.13% | ||
| Current year | -4.02% |
| 1 week | 0.55 |  | 0.65 |
| 1 month | 0.55 | | 1.05 |
| Current year | 0.55 | | 1.06 |
| 1 year | 0.46 | | 1.55 |
| 3 years | 0.46 | | 6.85 |
| 5 years | 0.46 | | 12.5 |
| 10 years | 0.46 | | 76.2 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 57 | 2024-08-30 | |
Michael Shankman
DFI | Director of Finance/CFO | 66 | 2024-09-30 |
John Docherty
PSD | President | 55 | 2015-04-14 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 65 | 2006-10-25 | |
Nicholas Baxter
BRD | Director/Board Member | 72 | 2011-07-07 |
John Docherty
BRD | Director/Board Member | 55 | 2016-04-28 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -3.06% | -2.89% | -41.37% | -19.97% | 14.68M | |
| -0.00% | +5.95% | +32.68% | +130.14% | 896B | |
| -1.77% | +2.44% | +49.81% | +42.28% | 546B | |
| -0.18% | +4.39% | +14.33% | +46.83% | 372B | |
| +0.88% | +2.38% | +24.30% | +14.35% | 328B | |
| -0.10% | +2.93% | +27.56% | +26.14% | 283B | |
| -0.79% | +2.16% | +31.97% | +12.94% | 282B | |
| -1.79% | 0.00% | +46.44% | -4.05% | 275B | |
| +0.91% | +3.07% | -29.86% | -47.76% | 206B | |
| -2.22% | -1.62% | +19.79% | +43.19% | 176B | |
| Average | -0.81% | +1.91% | +17.56% | +24.41% | 336.34B | |
| Weighted average by Cap. | -0.50% | +3.38% | +28.74% | +50.39% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | 1.4M 1.21M 1.1M 1.05M 1.93M 135M 1.96M 13.24M 5.12M 63.9M 5.27M 5.15M 223M |
| Net income | -6.4M -5.51M -5.04M -4.8M -8.81M -614M -8.95M -60.42M -23.38M -292M -24.02M -23.51M -1.02B | -8.95M -7.7M -7.04M -6.72M -12.31M -858M -12.52M -84.45M -32.68M -407M -33.58M -32.86M -1.42B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-05-15 | 0.5922 $ | -3.06% | 43,792 |
| 26-05-14 | 0.6109 $ | +1.41% | 120,805 |
| 26-05-13 | 0.6024 $ | +4.44% | 193,135 |
| 26-05-12 | 0.5768 $ | -4.63% | 305,340 |
| 26-05-11 | 0.6048 $ | -0.82% | 95,263 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- LEXX Stock
Select your edition
All financial news and data tailored to specific country editions
